Genentech Goes Roche?

South San Francisco biotechnology company Genentech, makers of some of the world's most boring prescription drugs ever (e.g., supplementary growth hormones Protropin and Nutropin, clot-busting pill TNKase, non-Hodgkins lymphomas treatment Rituxan, and zzzzzzz) might be bought out by Swiss drug company Roche. The European pill-pushers are offering the Bay Area company a whopping $43.7 billion. Genentech, though, is expected "to refuse the bid and strive to remain independent." Or, most likely, turn this offer down and strive to get a higher one.

Email This Entry


Comments (6) [rss]

What about Avastin and Herceptin? I guess that breast and colorectal cancer are too "boring" to mention.

can you crush and snort them for fun? if so, i stand corrected.

"The ones mother gives you do nothing at all..."

I didn't know they invented Rituxan. I had to be injected with it several times last year. Until that point, I'd never spent so much money on a drug which made me feel so unbelievably crappy. But the stuff worked.

Oh noes! Oh wait. I don't even care. Last week the Gav spoke to my conventioneering group about how safe for business he'd made the city principally as it concerns biotech and green tech... I hope the jobs don't leave. I work in a nonprofit and when company bosses are overseas, they obvs care less about the communities they do business in...

roche is the industry standard in fun stuff

roche is also the industry standard in evil.

Post a comment (Comment Policy)

Tips

About SFist

SFist is a website about San Francisco.

Editor: Brock Keeling
Publisher: Gothamist

Contribute

Latest Tip:

Looks like those OaklandIST restaurant or whatever people are butthurt about not being blogged about
[more]

Latest Photo:

Recent Comments

Subscribe

Use an RSS reader to stay up to date with the latest news and posts from SFist.

All Our RSS